Immune & Thymic

Thymopentin

Also known as TP-5 · TP5 · Timunox

Emerging researchSubcutaneous injectionIntramuscular injectionIntravenous injectionHistorically marketed as a therapeutic agent in some countries; NOT FDA-approved in the US. Not in broad pharmaceutical use in Western markets.

Thymopentin (TP-5) is a synthetic pentapeptide corresponding to the active region of the thymic hormone thymopoietin. It is studied for its ability to promote T-cell differentiation and modulate immune responses, and has been investigated in immunodeficiency-related conditions. It has a very short biological half-life, which has limited its broader pharmaceutical development. Controlled trials exist (for example, positive randomized trials in atopic dermatitis), though results in other conditions such as rheumatoid arthritis were inconsistent.

Studied / used for

Studied for T-cell differentiation and immune modulation
Studied in protocols for atopic dermatitis and IgE regulation
Studied for rheumatoid arthritis, with mixed trial results
Studied as an adjunct in immunodeficiency states

Commonly reported side effects

Injection-site reactions
Generally well tolerated in trials, with few serious adverse events reported

Emerging research. Active research; human evidence still developing. This reflects the strength of the research base, not effectiveness or a recommendation.

Not medical advice.

This is an educational reference. Peptalk does not recommend, prescribe, endorse, or rate any compound, and provides no dosing information. Do not start, stop, or change any peptide, hormone, supplement, or therapy based on this page. All clinical decisions must be made with your licensed healthcare provider.

← Back to all compounds